UnitedHealth Group, parent of UnitedHealthcare (the largest US insurer) and Optum (the largest US pharmacy-benefit manager, largest physician employer, and one of the largest healthcare data infrastructures), has become the country's largest healthcare organization through vertical integration. The pattern — insurers owning providers, PBMs owning pharmacies, providers owning hospitals — has spread across the industry. Whether vertical integration improves care, raises costs, or does both is the central empirical question of modern health-policy economics.
What UnitedHealth Owns
Optum's healthcare delivery arm employs or contracts with over 70,000 physicians, making UHG the largest single employer of US physicians by a wide margin. Optum Rx is among the three largest PBMs (with CVS Caremark and Express Scripts). Optum's data infrastructure handles claims and clinical data for hundreds of payers. Through acquisitions of Surgical Care Affiliates, DaVita Medical Group, Refresh Mental Health, and many others, the company has assembled what amounts to a vertically integrated healthcare conglomerate operating in payer, provider, pharmacy, and data layers simultaneously.
The competitive logic is that vertical integration captures margin that would otherwise leak to independent providers, pharmacies, or intermediaries. It also enables the insurer to direct patients to the provider arm, which produces volumes and pricing power the standalone businesses could not achieve.
The Theoretical Case For Integration
Care coordination is the standard argument. US healthcare is fragmented — a typical Medicare beneficiary sees seven different physicians annually, often with limited information flow between them. Vertical integration in principle solves this: the same organization employs the primary care physician, the specialist, the lab, the pharmacy. Information flows internally rather than across organizational boundaries. Care is coordinated by design.
If this worked as the theory suggests, vertically integrated delivery should produce better outcomes at lower cost — the "value-based care" promise. Some integrated systems (Kaiser Permanente, Geisinger, certain Veterans Affairs operations) do produce measurably better outcomes for their patients than fragmented alternatives. The question is whether the UnitedHealth/Optum model generalizes that pattern or whether it captures the rents of integration without delivering the coordination.
The Empirical Record
Several studies have examined vertically integrated insurer-provider operations.
Hospital-physician integration: when hospitals acquire physician practices, the empirical pattern is that prices charged for the physicians' services rise substantially (Capps, Dranove, Ody 2018), with no offsetting improvement in care quality (Baker, Bundorf, Kessler 2014, others). The integration captures price effects (higher prices because the integrated system can negotiate as a larger entity) without producing the coordination effects in the short run.
PBM-pharmacy integration: when PBMs own pharmacies, the empirical pattern is that the PBMs direct patients to their own pharmacies through formulary design and reimbursement structures, raising costs to plan sponsors (employers, government programs) and undermining independent pharmacies. The 2023-2024 wave of independent pharmacy closures, particularly in rural areas, is partly a consequence of this dynamic.
Insurer-provider integration in Medicare Advantage: insurer-owned provider organizations have higher MA enrollment than independent providers, and the enrollment is associated with the insurer's financial incentives in the MA risk-adjustment system. The combination has been a substantial profit driver for UnitedHealth and similar insurers.
The Risk-Adjustment Story
Medicare Advantage pays insurers based on the risk profile of their enrollees. Sicker enrollees produce higher payments. The risk-adjustment system relies on diagnosis codes that the insurer- owned providers submit. The DOJ has multiple ongoing investigations into whether MA insurers (including UnitedHealth) have systematically inflated diagnoses to capture excess payments — a phenomenon documented by MedPAC and the Office of Inspector General over years.
Eileen Appelbaum and Rosemary Batt's Private Equity at Work (2014) and subsequent work documents similar dynamics in PE-owned provider settings. The vertical-integration models, whether publicly-traded insurer-owned or PE-owned, share the structural incentive to optimize for revenue capture from public payers more than for care delivery improvements.
The Regulatory Response
The DOJ blocked the 2022 UnitedHealth-Change Healthcare merger on data-monopoly grounds, but the case settled on terms that allowed the acquisition to proceed with limited divestitures. The 2024 cyber-attack on Change Healthcare, owned by Optum after the merger, exposed how much of US healthcare claims infrastructure depended on a single acquired company.
The FTC has been more active on PBM scrutiny. The 2024 FTC interim report on PBMs found substantial evidence of self-dealing, discrimination against independent pharmacies, and patient-cost manipulation. The legislative responses — the PBM Transparency Act, the Pharmacy Benefit Manager Reform Act — have been introduced but not passed.
The State-Level Response
Several states have passed laws restricting PBM practices, requiring disclosure of PBM-pharmacy financial relationships, banning "spread pricing" (where the PBM charges plan sponsors more than it pays pharmacies and keeps the difference), and requiring "pass-through" pricing arrangements. The empirical evidence on whether these state reforms have moved costs is mixed and depends heavily on the specific provisions.
The state response is partial. PBMs operate nationally; state-level constraints are often circumvented through plan structures that shift the business outside the regulating state. The federal-level reform that would matter most has not happened.
The Single-Payer Counterfactual
Other developed countries with single-payer or single-payer-adjacent systems do not have the US vertical-integration pattern, because the payer is the government and there is no margin for private insurers to capture through provider integration. Whether this is a feature of single-payer or a bug depends on whether you think the integration is producing coordination benefits or rent-capture costs. The empirical record from the US suggests rent-capture dominates; from Germany or the Netherlands (multi-payer but heavily regulated) the vertical-integration pattern is less aggressive and produces fewer rent-capture concerns.
The Honest Reading
Healthcare vertical integration is the dominant business model trend in US healthcare and has been growing for two decades. The empirical evidence is that it captures rents — higher prices, more self-dealing, more direction of patients to the integrated arms — more than it produces the coordination benefits the theory promises. The regulatory response has been slow and partial. The underlying structural problem is that the US system's combination of multiple payers, private insurers, and fee-for-service incentives creates opportunities for vertical integration to extract value rather than to deliver coordination. Fixing this would require either substantially stronger antitrust enforcement, more aggressive PBM regulation, or a payment-system redesign that pushes value-based care more decisively. None of these has political momentum. The 2030s will probably see further consolidation absent a forcing event.